Autologous Bone Marrow Transplantation and Metformin, a Hope for the Cure of Multiple Sclerosis – Gilmore Health News

On Friday, June 5, a few days after World MS Day on May 30, there was a day of online conferences and workshops to learn more about multiple sclerosis. It was an opportunity to shed light on autologous bone marrow transplantation, a little known treatment that could cure multiple sclerosis.

Neuron

Multiple sclerosis (MS) is a neurodegenerative autoimmune disease that causes stiffness, pain, and fatigue. It is the main cause of disability, exclusion from the labor market, and social exclusion among young people, as it occurs mainly among people between 25 and 35 years old. According to the National MS Society, approximately 1 million people in the United States suffer from MS.

Currently, there is no treatment to cure MS, but there is hope: Autologous bone marrow transplantation or autologous hematopoietic stem cell transplantation. This treatment allows patients to go from the more common forms of multiple sclerosis into remission. If carried out early enough, it enables at least partial recovery from the disability.

Read Also: Combo of Diabetes and Hypertension Drugs Causes Cancer Cell Death, Researchers Find

The aim of this treatment is to rebuild a new immune system in patients. This includes intensive chemotherapy followed by reinjection of the patients hematopoietic stem cells. Several studies conducted between 2015 and 2019 on this technique have shown that 83.3 of patients with the relapsing-remitting form had no attack in the four years following auto-transplantation and three years after transplantation 78% of patients with secondary progressive multiple sclerosis and 66% of patients with primary progressive multiple sclerosis experienced no worsening of their disability, Mediapart continues.

One of the main obstacles to this treatment remains the difficulty of access. Many patients testify that their neurologist often finds this method too experimental and too risky. Another factor that discourages the use of autologous bone marrow transplantation is the risk-benefit ratio, which is considered unbalanced. Transplant-related mortality is between 5 and 10%, which justifies doctors preference for a treatment that is considered safer.

Read Also: Diabetes: Metformin Transfers Blood Sugar From the Blood to the Intestines

Another treatment has shown encouraging results in multiple sclerosis. This is a drug for diabetes, metformin, which rejuvenates stem cells to convert them into myelin-producing cells and thus help combat multiple sclerosis. These results have been published in the journal Cell Stem Cell, and it is expected that the tests, which are currently only carried out on mice, will also be carried out on humans within a year. I am very optimistic, study author Professor Robin Franklin told The Guardian newspaper.

References

Metformin Restores CNS Remyelination Capacity by Rejuvenating Aged Stem Cells

https://blogs.mediapart.fr/noelle-tassy/blog/300520/journee-mondiale-de-la-sep-et-si-parlait-du-traitement-dont-ne-parle-pas

Autologous Hematopoietic Cell Transplantation in Multiple Sclerosis: Changing Paradigms in the Era of Novel Agents

Read more from the original source:
Autologous Bone Marrow Transplantation and Metformin, a Hope for the Cure of Multiple Sclerosis - Gilmore Health News

R3 International Now Offering New Stem Cell Therapy Program for Lyme Disease in Mexico – Yahoo Finance

R3 Stem Cell International announced that it is now offering a new program with stem cell therapy for Lyme disease. R3 has been offering effective treatment at its international clinics for a while, but with the new program patients receive more cost effective options with 100 to 200 million stem cells involved.

SAN DIEGO, June 8, 2020 /PRNewswire-PRWeb/ -- R3 Stem Cell International announced that it is now offering a new program with stem cell therapy for Lyme disease. R3 has been offering effective treatment at its international clinics for a while, but with the new program patients receive more cost effective options with 100 to 200 million stem cells involved.

Stem cell treatment for Lyme disease in Mexico has been very effective at helping patients achieve symptom relief and regain an improved quality of life. Depending on a patient's history, the R3 International licensed provider will decide whether to add additional exosomes along with stem cells to the regimen.

The new program for Lyme disease involves either 150 million stem cells or 200 million. While these cell counts are incredibly high, it needs to be noted that the biologics come from a Mexico lab that achieves quality standards that exceed those of the FDA in the US.

There are two options for the Stem Cell Lyme disease program. One is a 5 day stay where Lyme patients receive several treatments during that time. The second option is for a patient to return to the Center for four visits over a year. The decision of which program to participate in is up to the patient and his/her family.

R3 Stem Cell International in Tijuana Mexico is only 20 minutes from the San Diego International Airport. R3 provides concierge escorted transportation to and from the clinic from San Diego, with hundreds of patients over the past year receiving successful care at the modern center.

The stem cell and exosome biologics used for Lyme disease care come from a lab that has an incredible safety record, and each treatment's biologic comes with a full Certificate of Analysis. Because Mexico allows stem cell culturing, the cell counts are extremely high with a viability of over 90%. No preservative is even necessary.

According to R3 International CEO David Greene, MD, MBA, "Patients and their families dealing with Lyme disease deserve a safe, clinically effective and cost effective option. We put that together in Mexico, with all inclusive treatment starting at $8975 which includes hotel and ground transportation. Tough conditions like Lyme disease necessitate large cell counts for optimal outcome, and most international centers charge 3 to 5 times our fees. Not with us!"

Each patient undergoes a free phone consultation with R3 International's licensed, experienced stem cell doctor. Simply call (888) 988-0515 to set one up.

SOURCE R3 Stem Cell International

See original here:
R3 International Now Offering New Stem Cell Therapy Program for Lyme Disease in Mexico - Yahoo Finance

Nick Cordero’s Wife Says His COVID-19 Recovery Is ‘Going in the Right Direction’ – countryliving.com

Nick Cordero's wife, Amanda Kloots, shared a hopeful update on her husband's condition as he continues to recover from his battle with COVID-19 and related complications.

In a series of videos posted to her Instagram stories on Sunday, Amanda said, "S0 I think this weekend was a good weekend, it was uneventful. Which, uneventful in the ICU is a good weekend. I think he had a weekend of rest, a weekend of growing, strength in his body and recovering a little bit."

"Not too many changes were made, which is also a good sign, but one really good sign is his white blood count number is way down," she continued. "So it has been as high as 65,000; we are now at 30,000. A frame of reference: a normal healthy person is around 15-20,000, even lower sometimes. So 30,000 is a great sign that things are moving in the right direction."

The Tony Award-nominated Broadway actor has been hospitalized at Cedars-Sinai Medical Center in Los Angeles for more than two months after being diagnosed with COVID-19.

Amanda's optimistic update comes almost a month after her husband woke up from a medically-induced coma and almost two months after he had his right leg amputated due to blood-clotting complications from the virus.

Nick, who is also known for his recurring roles on Blue Bloods and Law & Order: SVU, has started stem cell treatment to help his recovery, Amanda shared in another recent Instagram story.

"This could be really great ... Even if it just bridges us to the next level in healing for him," she said on Friday.

Amanda ended her weekend Instagram stories on a positive note, saying, "I don't know why I just have a really good feeling about this week, so I'm just gonna keep praying for our miracles and keep praying for that healing and God is with us ... Love you!"

We are also praying for Nick's full recovery and wishing him and his family all the best during this difficult time.

This content is created and maintained by a third party, and imported onto this page to help users provide their email addresses. You may be able to find more information about this and similar content at piano.io

This commenting section is created and maintained by a third party, and imported onto this page. You may be able to find more information on their web site.

See the original post here:
Nick Cordero's Wife Says His COVID-19 Recovery Is 'Going in the Right Direction' - countryliving.com

Memorial Sloan Kettering – Hackensack Meridian Health Partnership Announces Funding for Inaugural Immunology Research Collaboration Projects – The…

HACKENSACK, N.J. and NEW YORK, June 5, 2020 /PRNewswire/ -- As part of the Memorial Sloan Kettering Hackensack Meridian Health Partnership, the two organizations have formed an Immunology Research Collaboration. Through this joint initiative, researchers can apply for funding to support innovative investigations to explore the power of the immune system and ways it may be harnessed to fight cancer.

The three researchers with projects selected in 2020 for funding support over one to two years are:

"Immunotherapy has become an essential pillar of cancer treatment, but much remains to be discovered about the immune system and new ways to take advantage of its power to treat cancer effectively," said Paul Sabbatini, M.D., deputy physician-in-chief for clinical research at Memorial Sloan Kettering. "The Immunology Research Collaboration between Memorial Sloan Kettering and Hackensack Meridian Health gives researchers an opportunity to delve deeply into unexplored facets of the immune system, both in the lab and clinic, and speed discoveries that will ultimately contribute to reducing the burden of cancer on our patients, their families, and the world. We are enthusiastic about the potential of these three research projects and look forward to their results."

"While immunotherapy is revolutionizing cancer treatment, its benefits are not always sustainable over the long term," noted Andrew Goy, M.D., M.S., chairman and executive director of John Theurer Cancer Center and physician-in-chief of the Hackensack Meridian Health Oncology Care Transformation Service. "The work of these investigators will expand our knowledge of the immune system and glean new insights which may lead to novel immunotherapeutics that are more powerful and more durable than those we are using today. These projects capture the collaborative spirit of this initiative and could have a significant impact on patient outcomes."

ABOUTHACKENSACKMERIDIAN HEALTH

Hackensack Meridian Health is a leading not-for-profit health care organization that is the largest, most comprehensive and truly integrated health care network in New Jersey, offering a complete range of medical services, innovative research and life-enhancing care.

Hackensack Meridian Health comprises 17 hospitals from Bergen to Ocean counties, which includes three academic medical centers Hackensack University Medical Center in Hackensack, Jersey Shore University Medical Center in Neptune, JFK Medical Center in Edison; two children's hospitals - Joseph M. Sanzari Children's Hospital in Hackensack, K. Hovnanian Children's Hospital in Neptune; nine community hospitals Bayshore Medical Center in Holmdel, Mountainside Medical Center in Montclair, Ocean Medical Center in Brick, Palisades Medical Center in North Bergen, Pascack Valley Medical Center in Westwood, Raritan Bay Medical Center in Old Bridge, Raritan Bay Medical Center in Perth Amboy, Riverview Medical Center in Red Bank, and Southern Ocean Medical Center in Manahawkin; a behavioral health hospital Carrier Clinic in Belle Mead; and two rehabilitation hospitals - JFK Johnson Rehabilitation Institute in Edison and Shore Rehabilitation Institute in Brick.

Additionally, the network has more than 500 patient care locations throughout the state which include ambulatory care centers, surgery centers, home health services, long-term care and assisted living communities, ambulance services, lifesaving air medical transportation, fitness and wellness centers, rehabilitation centers, urgent care centers and physician practice locations. Hackensack Meridian Health has more than 35,000 team members, and 7,000 physicians and is a distinguished leader in health care philanthropy, committed to the health and well-being of the communities it serves.

The network's notable distinctions include having four hospitals among the top in New Jersey by U.S. News and World Report. Other honors include consistently achieving Magnet recognition for nursing excellence from the American Nurses Credentialing Center and being named to Becker's Healthcare's "150 Top Places to Work in Healthcare/2019" list.

The Hackensack Meridian School of Medicine at Seton Hall University opened in 2018, the first private medical school in New Jersey in more than 50 years, welcomed its second class of 96 students in 2019 to its ON3 campus in Nutley and Clifton. Additionally, the network partnered with Memorial Sloan Kettering Cancer Center to find more cures for cancer faster while ensuring that patients have access to the highest quality, most individualized cancer care when and where they need it.

Hackensack Meridian Health is a member of AllSpire Health Partners, an interstate consortium of leading health systems, to focus on the sharing of best practices in clinical care and achieving efficiencies.

For additional information, please visit http://www.HackensackMeridianHealth.org.

ABOUT MEMORIAL SLOAN KETTERING

As the world's oldest and largest private cancer center, Memorial Sloan Kettering has devoted more than 135 years to exceptional patient care, influential educational programs, and innovative research to discover more effective strategies to prevent, control and, ultimately, cure cancer. MSK is home to more than 20,000 physicians, scientists, nurses, and staff united by a relentless dedication to conquering cancer. Today, we are one of 51 National Cancer Institute-designated Comprehensive Cancer Centers, with state-of-the-art science and technology supporting groundbreaking clinical studies, personalized treatment, and compassionate care for our patients. We also train the next generation of clinical and scientific leaders in oncology through our continually evolving educational programs, here and around the world. Year after year, we are ranked among the top two cancer hospitals in the country, consistently recognized for our expertise in adult and pediatric oncology specialties. http://www.mskcc.org.

See the rest here:
Memorial Sloan Kettering - Hackensack Meridian Health Partnership Announces Funding for Inaugural Immunology Research Collaboration Projects - The...

Reports: F1 Legend Michael Schumacher is Set for Another Operation on His Road to Recovery – Essentially Sports

F1 and Ferrari legend Michael Schumacher is all set for another operation as he continues on his road to recovery. It has been 6 and a half years since Schumacher suffered a brain injury when he had a skiing accident in the French Alps. After the first couple of years, news has been scarce regarding the health of the 7-time world champion. However, in a bit of an update, Schumi is scheduled for a transfusion.

Italian source, Contro Copertina claims the aforementioned. They say that Dr Philippe Menasche, who is regarded as a pioneer in cell surgery will be in charge of the operation. Menasche was also in charge of a similar operation on Schumacher last year. Regarding the aim of the operation, Menasche said, The goal is to regenerate Michaels nervous system.

Dr Nicola Acciari claims that Michael Schumacher is suffering from muscle atrophy and osteoporosis. Both these conditions arise due to the lack of physical activity. Acciari adds, Over the past 20 years, science has made enormous progress in the field of stem cell treatment. But that doesnt change the fact that we still know little about the human brain. We are not able to say what results it (the treatment) will bring.

Earlier this year, When Dr Nicola Acciari spoke to Contro Copertina she had said, We must imagine a person very different from the one we remember on the track, with a very altered and deteriorated organic, muscular and skeletal structure. All as a result of the brain trauma he suffered.

Generally, the Schumachers have been very private about any news about the F1 legends health. However, Former Ferrari team principal, Jean Todt had revealed last year, that he had watched a race with Schumi at the Germans house in Switzerland. Todt said, He does not give up and keeps fighting.

We wish Schumi the best of luck on his road to recovery.

Go here to see the original:
Reports: F1 Legend Michael Schumacher is Set for Another Operation on His Road to Recovery - Essentially Sports

KOCO 5’s Zach Rael heading to California to help cousin with rare form of blood cancer – KOCO Oklahoma City

KOCO 5 reporter and anchor Zach Rael is heading to California to help his cousin in a battle against a rare form of blood cancer called myelofibrosis.Raels cousin reached out to him about eight months ago for him for help, saying her brother had been diagnosed with myelofibrosis. Rael said his cousin is doing well and there is an up-and-coming treatment that requires a healthy person to donate their stem cells from their blood.Ideally, the donor is a family member because there is a high chance of a match and a positive result, Rael posted on social media.Tests revealed that many family members were not suitable donors, so the family reached out to Rael and others with the hopes that someone would be a match. Rael submitted his DNA and, a few weeks later, learned he was a match.Rael took a flight Tuesday to California, where he will be for the next 10 days as part of the donation process.Over the next few days, I will be documenting my experience, he wrote. I plan on posting daily updates on my social media accounts and will be putting together a special story for air on KOCO when Im done.You can read Raels full story below:Hello everyone! I hope you are doing well on this Tuesday. Im writing this while on board an airplane somewhere over Arizona, on my way to Los Angeles, California. This is my first time flying post-pandemic. Besides the face masks - its been relatively normal.Unfortunately, this is not a vacation or a trip for fun.About 8 months ago my cousin Kathy (2nd cousin on my moms side) reached out to me asking for help. Her brother, my cousin Don, is battling Myelofibrosis, a rare form of blood cancer. While any type of cancer is scary, he is doing as well as he can and luckily there is an up and coming treatment used to treat it. The treatment essentially requires a healthy person to donate their stem cells from their blood to the person with cancer (Ill explain more on that later). Ideally, the donor is a family member because there is a high chance of a match and a positive result.Don and Kathy had already asked all their extended family to submit their DNA, but to no luck. No one came back as a suitable donor. So, they opened the search to extended family and I happily agreed to submit my DNA. Basically, I got a tube in the mail and was asked to spit in it. A few weeks later and I got a call from my cousins that I came back as a match to submit my stem cells to my cousin Don!Truth be told, before all of this, I was not very close with this side of my family. As it happens with extended family - we would only see each other at special family events like weddings, graduations, or funerals. So, I was a little surprised that I came back as a match. But I could not be more thrilled I did! This will be the best possible shot of giving cousin Don a chance to beat this thing!Flash forward to today. Ill be in California for the next 10 days as part of the donation process.A quick breakdown of what is to come: once I land, I will be going straight to City of Hope, the hospital system that is performing the donation and treating Don. They will be running some final tests on me this afternoon, including taking 20 of my vitals (Im told this is normal). Later this week I will have to take a COVID-19 test, an information class, and receive a few dosages of special shots. Ill be taking these shots once a day for 5 days before the donation. They help generate my stem cells so they are more easily extracted. One week from today will be my actual donation. It is a 6-8 hour process where I will be hooked up to a machine. They will take my blood from one arm, run it through a machine, and put my blood back in me through my other arm. Im told its just like giving blood.Over the next few days I will be documenting my experience (see the pic with all my equipment). I plan on posting daily updates on my social media accounts and will be putting together a special story for air on KOCO when Im done. My bosses at KOCO have been so understanding and willing to do what they can so I was able to come out to California for nearly two weeks. Im so thankful.Anyway this post is getting long. I hope you follow along and I hope to shed some light on what it is like to become a stem cell donor. There is a HUGE need for them.Talk soon. Cheers!-Zach

KOCO 5 reporter and anchor Zach Rael is heading to California to help his cousin in a battle against a rare form of blood cancer called myelofibrosis.

Raels cousin reached out to him about eight months ago for him for help, saying her brother had been diagnosed with myelofibrosis. Rael said his cousin is doing well and there is an up-and-coming treatment that requires a healthy person to donate their stem cells from their blood.

Ideally, the donor is a family member because there is a high chance of a match and a positive result, Rael posted on social media.

Tests revealed that many family members were not suitable donors, so the family reached out to Rael and others with the hopes that someone would be a match. Rael submitted his DNA and, a few weeks later, learned he was a match.

Rael took a flight Tuesday to California, where he will be for the next 10 days as part of the donation process.

Over the next few days, I will be documenting my experience, he wrote. I plan on posting daily updates on my social media accounts and will be putting together a special story for air on KOCO when Im done.

You can read Raels full story below:

Hello everyone! I hope you are doing well on this Tuesday. Im writing this while on board an airplane somewhere over Arizona, on my way to Los Angeles, California. This is my first time flying post-pandemic. Besides the face masks - its been relatively normal.

Unfortunately, this is not a vacation or a trip for fun.

About 8 months ago my cousin Kathy (2nd cousin on my moms side) reached out to me asking for help. Her brother, my cousin Don, is battling Myelofibrosis, a rare form of blood cancer. While any type of cancer is scary, he is doing as well as he can and luckily there is an up and coming treatment used to treat it. The treatment essentially requires a healthy person to donate their stem cells from their blood to the person with cancer (Ill explain more on that later). Ideally, the donor is a family member because there is a high chance of a match and a positive result.

Don and Kathy had already asked all their extended family to submit their DNA, but to no luck. No one came back as a suitable donor. So, they opened the search to extended family and I happily agreed to submit my DNA. Basically, I got a tube in the mail and was asked to spit in it. A few weeks later and I got a call from my cousins that I came back as a match to submit my stem cells to my cousin Don!

Truth be told, before all of this, I was not very close with this side of my family. As it happens with extended family - we would only see each other at special family events like weddings, graduations, or funerals. So, I was a little surprised that I came back as a match. But I could not be more thrilled I did! This will be the best possible shot of giving cousin Don a chance to beat this thing!

Flash forward to today. Ill be in California for the next 10 days as part of the donation process.

A quick breakdown of what is to come: once I land, I will be going straight to City of Hope, the hospital system that is performing the donation and treating Don. They will be running some final tests on me this afternoon, including taking 20 of my vitals (Im told this is normal). Later this week I will have to take a COVID-19 test, an information class, and receive a few dosages of special shots. Ill be taking these shots once a day for 5 days before the donation. They help generate my stem cells so they are more easily extracted. One week from today will be my actual donation. It is a 6-8 hour process where I will be hooked up to a machine. They will take my blood from one arm, run it through a machine, and put my blood back in me through my other arm. Im told its just like giving blood.

Over the next few days I will be documenting my experience (see the pic with all my equipment). I plan on posting daily updates on my social media accounts and will be putting together a special story for air on KOCO when Im done. My bosses at KOCO have been so understanding and willing to do what they can so I was able to come out to California for nearly two weeks. Im so thankful.

Anyway this post is getting long. I hope you follow along and I hope to shed some light on what it is like to become a stem cell donor. There is a HUGE need for them.

Talk soon. Cheers!

-Zach

Read the rest here:
KOCO 5's Zach Rael heading to California to help cousin with rare form of blood cancer - KOCO Oklahoma City

COVID-19 Impact on Global Cancer Stem Cell Therapy Industry 2020: Market Trends, Size, Share, Growth Applications, SWOT Analysis by Top Key Players…

The Global Cancer Stem Cell Therapy Market was estimated to be valued at USD XX million in 2019 and is projected to reach USD XX million by 2026, at a CAGR of XX% during 2019 to 2026.

The market is primarily driven by increasing number of cancer patients suffering from many different types of cancer. In addition, stem cell therapy is a painless and incision less treatment procedure is likely to boost the market growth.

However, lack of suitable and donor matching sample might restrict the market growth.

Get Sample Copy of this Report @ http://www.orianresearch.com/requestle/1040620

Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.

Top Key Companies Analyzed inGlobal Cancer Stem Cell Therapy Market are Thermo Fisher Scientific, Merck Kgaa, Bionomics, Lonza, Stemline Therapeutics, Miltenyi Biotec, Promocell, Macrogenics, Oncomed Pharmaceuticals and Irvine Scientific

Key Benefit of This Report:

Global Cancer Stem Cell Therapy Industry 2019 Market Research Report is spread across 121 pages and provides exclusive vital statistics, data, information, trends and competitive landscape details in this niche sector.

Inquire more or share a question if any before the purchase on this report @ http://www.orianresearch.com/040620

Target Audience:

Research Methodology:

The market is derived through extensive use of secondary, primary, in-house research followed by expert validation and third party perspective, such as, analyst reports of investment banks. The secondary research is the primary base of our study wherein we conducted extensive data mining, referring to verified data sources, such as, white papers, government and regulatory published articles, technical journals, trade magazines, and paid data sources.

For forecasting, regional demand & supply factors, recent investments, market dynamics including technical growth scenario, consumer behavior, and end use trends and dynamics, and production capacity were taken into consideration.

Different weightages have been assigned to these parameters and quantified their market impacts using the weighted average analysis to derive the market growth rate.

The market estimates and forecasts have been verified through exhaustive primary research with the Key Industry Participants (KIPs), which typically include:

Get Direct Copy of this Report @ http://www.orianresearch.com/checkout/1040620

Major Points Covered in Table of Contents:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Global Cancer Stem Cell Therapy Market Overview

5 Global Cancer Stem Cell Therapy Market, by Product Type

6 Global Cancer Stem Cell Therapy Market, by Application

7 Global Cancer Stem Cell Therapy Market by Region

8 Competitive Landscape

9 Company Profiles

10 Key Insights

Customization Service of the Report:Orian Research provides customisation of reports as per your need. This report can be personalised to meet your requirements. Get in touch with our sales team, who will guarantee you to get a report that suits your necessities.

About Us:Orian Research is one of the most comprehensive collections of market intelligence reports on the World Wide Web. Our reports repository boasts of over 500000+ industry and country research reports from over 100 top publishers. We continuously update our repository so as to provide our clients easy access to the worlds most complete and current database of expert insights on global industries, companies, and products. We also specialize in custom research in situations where our syndicate research offerings do not meet the specific requirements of our esteemed clients.

Contact Us:Ruwin MendezVice President Global Sales & Partner RelationsOrian Research ConsultantsUS: +1 (832) 380-8827 | UK: +44 0161-818-8027Email:[emailprotected]Website: http://www.orianresearch.com/

Read more:
COVID-19 Impact on Global Cancer Stem Cell Therapy Industry 2020: Market Trends, Size, Share, Growth Applications, SWOT Analysis by Top Key Players...

Saudi Govt. Stresses Need to Respect COVID-19 Preventive Measures – Asharq Al-awsat – English

The Saudi government stressed on Tuesday the need for citizens and residents to adhere to the preventive measures aimed at curbing the novel coronavirus.

Custodian of the Two Holy Mosques King Salman bin Abdulaziz chaired the virtual cabinet meeting.

The ministers reviewed the measures the Kingdom has been taking to ease the restrictions imposed over the outbreak.

King Salman emphasized that the health of the citizens and residents was his top priority.

The cabinet hailed the huge support King Salman and Crown Prince Mohammed bin Salman, Deputy Prime Minister and Minister of Defense, have offered the concerned sectors, allowing them to improve their efforts in preparing for and containing the outbreak.

They praised the concerned authorities for raising awareness among the people, maintaining the health sector and doubling the capacities of labs, intensive care units and number of ventilators.

The cabinet expressed its great confidence in the capacity of the health sector and its advanced capabilities, which were provided by the wise leadership through financial and moral support.

It noted the states investment in the health infrastructure over the years, which has allowed it to respond rapidly and with high efficiency to the challenges caused by the pandemic. This has enabled it to provide health care to all despite the difficult conditions sparked by the outbreak and effectively saving lives.

The government also addressed last week's 2020 donor conference for Yemen that was hosted by Saudi Arabia in partnership with the United States at the directives of King Salman and Crown Prince Mohammed. The event saw the participation of 126 parties from 66 countries, as well as several UN and non-government agencies. The conference pledged 1.35 billion dollars for Yemen, including 50 million pledged by Saudi Arabia.

The Kingdom will continue to support the Yemeni people and exert all efforts to reach a sustainable political solution to their conflict.

The cabinet reviewed the latest regional and international developments. It again welcomed Egypts efforts that are aimed at resolving the Libyan conflict. The Cairo Declaration, announced on Saturday, called for a ceasefire, resuming political talks and electing a leadership council.

The ministers also rejected Israels plans to annex territories in the occupied West Bank, condemning any potential unilateral measures and any violations of international resolutions. The ministers also expressed their rejection of any move that would hamper the resumption of the peace process that is aimed at achieving security and stability in the region. Saudi Arabia remains committed to Palestinian people and their choices.

See the rest here:
Saudi Govt. Stresses Need to Respect COVID-19 Preventive Measures - Asharq Al-awsat - English

‘Blue Bloods’ Star Nick Cordero’s Wife Amanda Kloots Says He Had Uneventful Weekend at the Hospital – AmoMama

Nick Cordero's wife, Amanda Kloots, says the "Blue Bloods" star had an uneventful weekendshe claims his recovery is headed in the right direction.

Amanda Kloots, Nick Cordero's wife, has stated that her hubby had an "uneventful" weekend in the ICU as he continues to recuperate from complications he's endured after his battle with COVID-19.

The famous actor was taken into the ICU earlier in April when he was admitted with the telltale symptoms of COVID-19. Since then, he has battled ailments ranging from lung infections to blood clots that left the doctors no choice but to amputate his leg.

Cordero has since woken up from his coma and is reportedly on the mend.His wife had this to say on a video shesharedto her Instagram story on Sunday:

"So I think this weekend was a good weekend, it was uneventful," she began. "Which, uneventful in the ICU is a good weekend. I think he had a weekend of rest, a weekend of growing..."

Kloots added that though not many changes have been recorded, there's an indication that he is well on his way to recovery Cordero's white blood cell count number has reduced drastically.

The count, which waspreviouslyas high as 65,000, is now down to 30,000. An average healthy person's white blood cell count is said to be between 15-20,000, sometimes lower.

The news comes just days following Kloots' exciting revelation that her husband would bestartingstem cell treatment to aid his recuperation. In a video posted on her Instagram story, Kloots said:

"We have started stem cell treatment for Nick, and that just finished. We decided on this a couple of days ago, and the hospital got it moving."

She admitted that while there were no guarantees the treatment would work, she was hoping it wouldrepair and strengthen Cordero's lungs.On Wednesday, Klootssharedher optimism for her hubby's complete recovery even though she'd been warned several times that he wouldn't make it.

View this post on Instagram

This was sent to me, painted by @shanilevinart I cannot believe the love and support we have received from this army we have fighting with us! From paintings, singing, posting, helping, sharing medical info, dinners, homes, cars, babysitting, gifts, flowers- I honestly cant list it all. It takes a village and I couldnt do it without all of you! THANK YOU SO MUCH!

A post shared by AK! (@amandakloots) on Jun 7, 2020 at 5:06pm PDT

Sheshareda photo of Cordero kissing baby Elvis on the cheek. In her caption, she admitted that she had been advised multiple times to say her farewells because it would take a miracle for Cordero to recover.

Kloots saidshe has faitha faith that may have paid off as she admitted that her husband's health gets a little better every day thanks to the various treatments being administered to him.

The treatmentsincludeadministering new antibiotics and vitamins, cleaning out his lungs, laying him down in a prone position, and, most recently, the stem cell treatment.

The proning has been noted to help immensely as it aids theexchangeof oxygen and gas. According to Kloots, doctors will keep Cordero in the prone position for 16 to 20 hours intervals as a form of treatment. Godspeed Cordero!

See more here:
'Blue Bloods' Star Nick Cordero's Wife Amanda Kloots Says He Had Uneventful Weekend at the Hospital - AmoMama

Animal Stem Cell Therapy Sales Market 2019 Break Down by Top Companies, Countries, Applications, Challenges, Opportunities and Forecast 2026 – Cole of…

A new market report by Market Research Intellect on the Animal Stem Cell Therapy Sales Market has been released with reliable information and accurate forecasts for a better understanding of the current and future market scenarios. The report offers an in-depth analysis of the global market, including qualitative and quantitative insights, historical data, and estimated projections about the market size and share in the forecast period. The forecasts mentioned in the report have been acquired by using proven research assumptions and methodologies. Hence, this research study serves as an important depository of the information for every market landscape. The report is segmented on the basis of types, end-users, applications, and regional markets.

The research study includes the latest updates about the COVID-19 impact on the Animal Stem Cell Therapy Sales sector. The outbreak has broadly influenced the global economic landscape. The report contains a complete breakdown of the current situation in the ever-evolving business sector and estimates the aftereffects of the outbreak on the overall economy.

Get Sample Copy with TOC of the Report to understand the structure of the complete report @ https://www.marketresearchintellect.com/download-sample/?rid=240104&utm_source=COD&utm_medium=888

The report also emphasizes the initiatives undertaken by the companies operating in the market including product innovation, product launches, and technological development to help their organization offer more effective products in the market. It also studies notable business events, including corporate deals, mergers and acquisitions, joint ventures, partnerships, product launches, and brand promotions.

Leading Animal Stem Cell Therapy Sales manufacturers/companies operating at both regional and global levels:

Sales and sales broken down by Product:

Sales and sales divided by Applications:

The report also inspects the financial standing of the leading companies, which includes gross profit, revenue generation, sales volume, sales revenue, manufacturing cost, individual growth rate, and other financial ratios.

The report also focuses on the global industry trends, development patterns of industries, governing factors, growth rate, and competitive analysis of the market, growth opportunities, challenges, investment strategies, and forecasts till 2026. The Animal Stem Cell Therapy Sales Market was estimated at USD XX Million/Billion in 2016 and is estimated to reach USD XX Million/Billion by 2026, expanding at a rate of XX% over the forecast period. To calculate the market size, the report provides a thorough analysis of the market by accumulating, studying, and synthesizing primary and secondary data from multiple sources.

To get Incredible Discounts on this Premium Report, Click Here @ https://www.marketresearchintellect.com/ask-for-discount/?rid=240104&utm_source=COD&utm_medium=888

The market is predicted to witness significant growth over the forecast period, owing to the growing consumer awareness about the benefits of Animal Stem Cell Therapy Sales. The increase in disposable income across the key geographies has also impacted the market positively. Moreover, factors like urbanization, high population growth, and a growing middle-class population with higher disposable income are also forecasted to drive market growth.

According to the research report, one of the key challenges that might hinder the market growth is the presence of counter fit products. The market is witnessing the entry of a surging number of alternative products that use inferior ingredients.

Key factors influencing market growth:

Reasons for purchasing this Report from Market Research Intellect

Customized Research Report Using Corporate Email Id @ https://www.marketresearchintellect.com/need-customization/?rid=240104&utm_source=COD&utm_medium=888

Customization of the Report:

Market Research Intellect also provides customization options to tailor the reports as per client requirements. This report can be personalized to cater to your research needs. Feel free to get in touch with our sales team, who will ensure that you get a report as per your needs.

Thank you for reading this article. You can also get chapter-wise sections or region-wise report coverage for North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

To summarize, the Animal Stem Cell Therapy Sales market report studies the contemporary market to forecast the growth prospects, challenges, opportunities, risks, threats, and the trends observed in the market that can either propel or curtail the growth rate of the industry. The market factors impacting the global sector also include provincial trade policies, international trade disputes, entry barriers, and other regulatory restrictions.

About Us:

Market Research Intellect provides syndicated and customized research reports to clients from various industries and organizations with the aim of delivering functional expertise. We provide reports for all industries including Energy, Technology, Manufacturing and Construction, Chemicals and Materials, Food and Beverage and more. These reports deliver an in-depth study of the market with industry analysis, market value for regions and countries and trends that are pertinent to the industry.

Contact Us:

Mr. Steven Fernandes

Market Research Intellect

New Jersey ( USA )

Tel: +1-650-781-4080

Follow this link:
Animal Stem Cell Therapy Sales Market 2019 Break Down by Top Companies, Countries, Applications, Challenges, Opportunities and Forecast 2026 - Cole of...